verified SJR 0,561 · Q3 • database Scopus / SJR & Web of Science indexed

Germany · Springer Science and Busines...

workspace_premium Q3 — Oncology lock_open Open Access

Journal of the Egyptian National Cancer Institute

Journal of the Egyptian National Cancer Institute is a journal indexed in SJR in Oncology and Cancer Research with an H index of 30. It is an CC BY Journal It has an SJR impact factor of 0,561 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,561.

ISSN: 1110-0362

Publisher: Springer Science and Business Media Deutschland GmbH

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,561 Q3

H-index 30

Acceptance rate pie_chart

38%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,561

H-index

Docs (year)

Docs 3y

141

Total refs

1848

Cites 3y

273

Citable 3y

139

Cites/Doc 2y

1.71

Ref/Doc

42.0

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Breast cancer with inguinal node recurrence

WITHDRAWN: Molecular classification of colorectal cancer: Current perspectives and controversies

Corrigendum to "Outcome of pediatric parameningeal rhabdomyosarcoma. The Children Cancer Hospital, Egypt experience" [J Egypt Natl Cancer Instit 2013;25:79-86]

Corrigendum to "Acute promyelocytic leukemia, study of predictive factors for Differentiation Syndrome, single center experience" [J. Egypt. Natl. Cancer Inst. 25 (1) (2013) 13-19]

Congenital peripheral primitive neuroectodermal tumor: A case treated successfully with multimodality treatment

Comparison of abdominoperineal resection and low anterior resection in lower and middle rectal cancer

Comparative study between the effect of methotrexate and valproic acid on solid Ehrlich tumour

Comparative dosimetric evaluation of three-dimensional conformal and stereotactic radiotherapy for treatment of intracranial tumors

Clinico-pathological features of breast carcinoma in elderly Egyptian patients: A comparison with the non-elderly using population-based data

Clinical significance of anaplasia in childhood rhabdomyosarcoma

Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt

Clinical experience in pediatric neuroblastoma intensity modulated radiotherapy

SHOW MORE ARTICLES

CCAAT/enhancer binding protein a gene expression in Egyptian patients with acute myeloid leukemia

Adhesion molecules expression in CLL: Potential impact on clinical and hematological parameters

Bone metastasis in breast cancer: The story of RANK-Ligand

Bladder cancer and schistosomiasis

Bilateral clear cell sarcoma of the kidney

Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients

Axillary metastasis in clinically node-negative breast cancer

Angiomyolipoma of the kidney: Clinicopathological and immunohistochemical study

An accelerated hypofractionated schedule with a daily concomitant boost after breast conservation surgery: the feasibility and toxicity

Alveolar soft part sarcoma of orbit: A rare diagnosis

Advancement flaps are enough in most cases as oncoplastic technique for breast cancer even with central or periareolar localization

Adjuvant radiotherapy in the treatment of gall bladder carcinoma: What is the current evidence

FAQs

Journal of the Egyptian National Cancer Institute has an SJR of 0,561 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Journal of the Egyptian National Cancer Institute is 38%.

Journal of the Egyptian National Cancer Institute

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of the Egyptian National Cancer Institute?

What is the APC / publication cost?

What is the acceptance rate?